York, United Kingdom, Aug 13, 2013 — A recent study by Current Partnering (http://www.currentpartnering.com/2013/08/13/top-15-most-partnered-therapeutic-targets/) identifies the most partnered therapeutic targets in recent years.
The study titled Trends in Therapeutic Partnering is a new report from Current Partnering. Full details available here: https://www.currentpartnering.com/2013/08/13/top-15-most-partnered-therapeutic-targets/
The study identified 35 therapeutic targets where more than 100 partnering deals have been announced during the period 2007 to mid-2013.
A summary article is available which offers a review the top 15 specific therapeutic targets based on most partnering deals announced. View article: Top 15 Most Partnered Therapeutic Targets
The full report can be viewed here: Trends in Therapeutic Partnering
Not surprisingly the list is dominated by chronic and life threatening conditions, many of which present in later stages of life. Examples include numerous cancers, infectives, other chronic later life conditions.
These therapeutic areas represent an attractive opportunity and unmet need for many big pharma and big biotech companies.
As a result, the deal making is dominated by top pharma/biotech companies in-licensing from smaller companies in return for upfront, milestone and royalty streams should product candidates make it to market.
In addition, there is much activity between companies/academia for discovery research in these therapeutic areas.
The top 15 therapeutic targets according to number of partnering deals announced since 2007 are:
- Breast cancer
- Alzheimer’s disease
- Lung cancer
- Wound healing
- Prostate cancer
- Rheumatoid arthritis
- Colorectal cancer
- Solid tumors
A summary of the top 15 targets for partnering can be viewed here: http://www.currentpartnering.com/2013/08/13/top-15-most-partnered-therapeutic-targets/
The article and partnering data were sources from the Trends in Therapeutic Partnering report.
The report provides an in depth analysis of deal trends for these and another thirty leading targets according to deals announced.
For each target, a comprehensive listing of all deals is provided, including a link to the full deal record at Current Agreements, the leading deals and alliances database for the life sciences.
This brand new market intelligence report includes:
- Trends in therapeutic dealmaking in the biopharma industry since 2007
- Analysis of therapeutic partnering deal structure
- Access to over 5,000 therapeutic partnering deals
- The top 35 therapeutic targets for partnering since 2007
- The leading partnering deals by value since 2007
- Most active partnering dealmakers since 2007
Fully up to date, this research report provides details of the top 35 targets in terms of deal activity from 2007 to mid 2013.
The Trends in Therapeutic Partnering report detailed understanding and analysis of the 35 most popular therapeutic targets for partnering in the period 2007 to mid 2013.
Using this report, deal makers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of therapeutic partnering trends since 2007, together with insight into which companies are active in each of the thirty five leading therapeutic areas.
This report contains over 5,200 links to online copies of actual partnering deals as recorded at Current Agreement, together with contract documents if submitted to the Securities Exchange Commission by big biotech and their partners.
Table of Contents
Full table of contents and list of figures: http://reports.currentpartnering.com/reports/trends-in-therapeutic-partnering-order.html
- Executive Summary
- Chapter 1 – Introduction
- Chapter 2 – Trends in therapeutic deal making activity
- Chapter 3 – Leading therapy deals by value
- Chapter 4 – Submitting opportunities to therapeutic target partner companies
- Chapter 5 – Forthcoming therapeutic partnering events
- Chapter 6 – Top 35 therapeutic partnering targets
- Chapter 7 – Resources
Therapeutic targets profiled
Congestive heart disease
To order this report: Trends in Therapeutic Partnering
Fax: +44 8709 305993
Sector: Pharmaceuticals, Biotechnology
Source: Current Partnering